The better-than-expected loss per share could be seen positively by investors, indicating potential operational efficiency or cost management. However, the miss on sales forecasts could raise concerns about revenue growth and market demand for Kymera's products. The mixed results make the short-term impact on the stock price uncertain, hence a neutral score.